These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 13024
1. [Clinical trials of anti-angina drugs]. Camerini E, Alberti E, Borgioni L, Medugno G, Scardi S. G Ital Cardiol; 1976; 6(7):1291-304. PubMed ID: 13024 [No Abstract] [Full Text] [Related]
2. [Clinical trial of anti-angina drugs in Italy (1963-1974)]. Scardi S, Alberti E, Borgioni L, Camerini F. G Ital Cardiol; 1976; 6(6):978-86. PubMed ID: 14863 [No Abstract] [Full Text] [Related]
4. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris. Aellig WH, Prichard BN, Richardson GA. Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674 [No Abstract] [Full Text] [Related]
5. [Progress in the conservative treatment of angina pectoris]. Martin KL, Kaltenbach M. Hippokrates; 1973 Oct; 44(3):269-83. PubMed ID: 4148945 [No Abstract] [Full Text] [Related]
6. Investigation of verapamil in the treatment of angina pectoris. Sandler G. Brux Med; 1970 Sep; 50(9):669-73. PubMed ID: 4928626 [No Abstract] [Full Text] [Related]
8. [Adrenergic beta receptor blockaders and nitrites in the treatment of angina pectoris]. Haarmann K, Neff K. Schweiz Rundsch Med Prax; 1974 Mar 26; 63(12):355-9. PubMed ID: 4150716 [No Abstract] [Full Text] [Related]
9. [Clinical evaluation of anti-angina agents: studies in Italy (1963-1974)]. Scardi S, Alberti E, Borgioni L, Medugno G, Camerini F. Boll Soc Ital Cardiol; 1976 Mar 26; 21(9):1557-9. PubMed ID: 21675 [No Abstract] [Full Text] [Related]
10. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance]. Specchia G, Marsico F, Micheletti T, Bona M. Cardiologia; 1995 Dec 26; 40(12 Suppl 1):91-5. PubMed ID: 8998788 [No Abstract] [Full Text] [Related]
11. [Ethical problems in antiangina drug experimentation]. Vastesaerger M. Brux Med; 1970 Sep 26; 50(9):675-6. PubMed ID: 4928627 [No Abstract] [Full Text] [Related]
12. [Clinical evaluation of adrenergic beta blocking agents in angina pectoris in a double blind trial]. Saad EA, Prazeres PR, Siqueira PL, Amarante A, Levy S, Benchimol AB. Arq Bras Cardiol; 1971 Feb 26; 24(1):7-16. PubMed ID: 4399358 [No Abstract] [Full Text] [Related]
13. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies. Szwed H, Hradec J, Préda I. Coron Artery Dis; 2001 Feb 26; 12 Suppl 1():S25-8. PubMed ID: 11286304 [Abstract] [Full Text] [Related]
14. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris. Frick MH, Katila M. Fortn Rev Chic Dent Soc; 1970 Sep 01; 60(5):96-101. PubMed ID: 4393719 [No Abstract] [Full Text] [Related]
15. Proceedings: A comparative study of perhexiline, beta-adrenergic blocking agents and placebos in the management of angina pectoris. Armstrong ML. Postgrad Med J; 1973 Apr 01; 49():Suppl 3:108-12. PubMed ID: 4587026 [No Abstract] [Full Text] [Related]
19. Proceedings: Influence of perhexiline on the effort tolerance test in angina pectoris. Comparison with placebo and prenylamine. Cherchi A, Bina M, Fonzo R, Raffo M. Postgrad Med J; 1973 Apr 01; 49():Suppl 3:67-74. PubMed ID: 4587035 [No Abstract] [Full Text] [Related]